Building Capacity for a Sustainable, Country-led Response to the HIV/AIDS Epidemic in Guyana: A Technical Assistance Support Model to the Guyana Ministry of Health (MOH) under the President's Emergency Plan for AIDS
The summary for the Building Capacity for a Sustainable, Country-led Response to the HIV/AIDS Epidemic in Guyana: A Technical Assistance Support Model to the Guyana Ministry of Health (MOH) under the President's Emergency Plan for AIDS grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.
Building Capacity for a Sustainable, Country-led Response to the HIV/AIDS Epidemic in Guyana: A Technical Assistance Support Model to the Guyana Ministry of Health (MOH) under the President's Emergency Plan for AIDS: Approach:
Activities
Outcomes
Short Term Outcomes
(1-2 Years)
Intermediate Outcomes
(3-4 Years)
Long Term Outcomes
(5+ Years)
Conduct operational assessment of current key populations (KP) HIV programs
Detail the level of adherence/compliance of MOH program managers and senior staff to key population program implementation requirements
Identify operational gaps in key populations’ program delivery (stock-outs of materials, difficulty recruiting and retaining providers, inability to reach targeting populations using recommended strategy, etc.)
Develop new and revised key populations’ programming addressing operational and uptake challenges identified by administrators and end-users
Inform provider training agenda based on self-reported needs of HIV-infected key populations
Conduct end-user assessment of current key populations HIV programs
Identify barriers to access and uptake of clinical services by HIV-infected members of key populations
Describe preferred service delivery options as reported by HIV-infected key populations (e.g. hours of operation, location, attending clinical staff type, clinical service gaps)
Increased access to HIV clinical services for key populations
Improved uptake of HIV clinical services by key populations
Reduced disparities between the general and key populations in HIV transmission and clinical outcomes (e.g. GP prevalence 0.8-1.3% vs KP prevalence 19-24%)
Provide HIV best clinical practices trainings to clinicians at national and regional sites (offering should be open to clinical staff from NGOs)
Increased adherence of clinicians to international HIV clinical and treatment guidelines
Increased provider awareness of operational strategies for clinical management of HIV-infected members of key populations
Increased collaborative care provision between national clinical treatment centers and civil society care and support organizations
Increased access to and quality of HIV clinical care, especially for MSM and commercial sex workers (CSW)
Improved linkage to and retention in care, especially for MSM and CSW
Develop and pilot a single, consolidated HIV/AIDS care quality improvement strategy and assessment tool
Implement and integrate consolidated HIV/AIDS care quality improvement strategy and assessment tool
Increased efficiency in monitoring quality of care at the main MOH service delivery sites (efficiency as indicated by the number of administrative areas assessed in a visit and number of measures included in a single chart review)
Improved quality of care at the main MOH service delivery sites
Increased documentation of linkage to care
Design and develop a pilot HIV/AIDS electronic database for patient monitoring
Implement and integrate HIV/AIDS electronic database for patient monitoring
Increased availability of strategic information (SI) for patient monitoring (adherence, CD4 count, viral load, HIV genotyping and phenotyping where applicable)
Improved ability to use patient data for program monitoring at the national level
Develop, pilot and implement a patient linking strategy with a single, robust patient unique identifier across all MOH programs
Improved case tracking of HIV-infected clients across other MOH programs (e.g. TB, STI, PMTCT)
Increased integration of HIV care with other comorbid conditions under the MOH management
Improved quality of care
Improved patient outcomes as documented in chart reviews and patient monitoring databases
Develop and pilot an enhanced surveillance strategy for National AIDS Program Secretariat (NAPS) data linkage
Decreased client duplication across multiple monitoring indicators used for reporting
Increased cost savings by reducing excessive procurement spending (test kits, drugs, educational materials etc.)
Develop and pilot a revised case surveillance form to include transmission risk
Increased volume and quality of strategic information on key populations and other vulnerable group
Increased data utilization for program targeting to reach MSM, CSW and transgender (TG)
Increased data reporting on KP and vulnerable groups (risk and outcomes)
Conduct data management and analysis trainings
Increased capacity of HIV program officers for data analysis within the MOH
Increased country ownership for HIV data management and utilization
Improved program monitoring and evaluation
Conduct HIV Drug Resistance (HIVDR) testing
Report HIVDR trends among enrolled care patients
Increased availability of strategic information to revise treatment guidelines with specific emphasis on the management of drug resistance for regimen selection and switching
Reduced incidence of acquired HIV Drug Resistance
Reduced HIV-related morbidity and mortality
Conduct open case conferences with NGOs at the National Care and Treatment Center (NCTC)
Reduced loss to care
Increased rate of patient re-engagement after loss to care
Increased proportion of patients retained in care
Improved quality of HIV care
Reduced HIV-related morbidity and mortality
Conduct routine adherence assessments and transmission risk reassessment among retained care clients
Improved detection of adherence challenges
Reduced incidence of treatment failure
Reduced incidence of acquired drug resistance
Improved quality of HIV clinical care
Reduced viral load
Reduced incidence of opportunistic infections
Develop and pilot an HIV/AIDS-specific quality improvement strategy and assessment tool for laboratory services
Increased availability of strategic information around laboratory performance
Reduced turnaround time for HIV confirmatory test results
Increased quality checks for rapid testing using gold standards (ELISA and Western Blot)
Improved quality of laboratory service delivery
Maintenance of a safe blood supply
Conduct an HIV drug resistance capacity assessment at national public health reference laboratory (NPHRL)
Increased availability of strategic information around HIVDR testing at NPHRL
Increased data for decision making ability around initiating HIVDR testing locally and the required inputs
Monitor current infection control practices at HIV and TB care sites
Decreased risk of TB/HIV nosocomial infections
Decreased incidence of TB among HIV-infected patients in care
Reduced TB/HIV-related morbidity and mortality for the coinfected
Develop a clinical cascade at the national level for ongoing program monitoring and evaluation (M&E)
Improved program management by highlighting areas of need across the continuum of care
Improved program quality
Reduced HIV-related morbidity and mortality
Establish and build capacity for Caribbean regional support, including analysis
Increased collaboration with peers and technical support resources within the Caribbean region
Increased availability of sustainable HIV technical assistance outside of USG or international multilaterals
Activities
Outcomes
Short Term Outcomes
(1-2 Years)
Intermediate Outcomes
(3-4 Years)
Long Term Outcomes
(5+ Years)
Conduct operational assessment of current key populations (KP) HIV programs
Detail the level of adherence/compliance of MOH program managers and senior staff to key population program implementation requirements
Identify operational gaps in key populations’ program delivery (stock-outs of materials, difficulty recruiting and retaining providers, inability to reach targeting populations using recommended strategy, etc.)
Develop new and revised key populations’ programming addressing operational and uptake challenges identified by administrators and end-users
Inform provider training agenda based on self-reported needs of HIV-infected key populations
Conduct end-user assessment of current key populations HIV programs
Identify barriers to access and uptake of clinical services by HIV-infected members of key populations
Describe preferred service delivery options as reported by HIV-infected key populations (e.g. hours of operation, location, attending clinical staff type, clinical service gaps)
Increased access to HIV clinical services for key populations
Improved uptake of HIV clinical services by key populations
Reduced disparities between the general and key populations in HIV transmission and clinical outcomes (e.g. GP prevalence 0.8-1.3% vs KP prevalence 19-24%)
Provide HIV best clinical practices trainings to clinicians at national and regional sites (offering should be open to clinical staff from NGOs)
Increased adherence of clinicians to international HIV clinical and treatment guidelines
Increased provider awareness of operational strategies for clinical management of HIV-infected members of key populations
Increased collaborative care provision between national clinical treatment centers and civil society care and support organizations
Increased access to and quality of HIV clinical care, especially for MSM and commercial sex workers (CSW)
Improved linkage to and retention in care, especially for MSM and CSW
Develop and pilot a single, consolidated HIV/AIDS care quality improvement strategy and assessment tool
Implement and integrate consolidated HIV/AIDS care quality improvement strategy and assessment tool
Increased efficiency in monitoring quality of care at the main MOH service delivery sites (efficiency as indicated by the number of administrative areas assessed in a visit and number of measures included in a single chart review)
Improved quality of care at the main MOH service delivery sites
Increased documentation of linkage to care
Design and develop a pilot HIV/AIDS electronic database for patient monitoring
Implement and integrate HIV/AIDS electronic database for patient monitoring
Increased availability of strategic information (SI) for patient monitoring (adherence, CD4 count, viral load, HIV genotyping and phenotyping where applicable)
Improved ability to use patient data for program monitoring at the national level
Develop, pilot and implement a patient linking strategy with a single, robust patient unique identifier across all MOH programs
Improved case tracking of HIV-infected clients across other MOH programs (e.g. TB, STI, PMTCT)
Increased integration of HIV care with other comorbid conditions under the MOH management
Improved quality of care
Improved patient outcomes as documented in chart reviews and patient monitoring databases
Develop and pilot an enhanced surveillance strategy for National AIDS Program Secretariat (NAPS) data linkage
Decreased client duplication across multiple monitoring indicators used for reporting
Increased cost savings by reducing excessive procurement spending (test kits, drugs, educational materials etc.)
Develop and pilot a revised case surveillance form to include transmission risk
Increased volume and quality of strategic information on key populations and other vulnerable group
Increased data utilization for program targeting to reach MSM, CSW and transgender (TG)
Increased data reporting on KP and vulnerable groups (risk and outcomes)
Conduct data management and analysis trainings
Increased capacity of HIV program officers for data analysis within the MOH
Increased country ownership for HIV data management and utilization
Improved program monitoring and evaluation
Conduct HIV Drug Resistance (HIVDR) testing
Report HIVDR trends among enrolled care patients
Increased availability of strategic information to revise treatment guidelines with specific emphasis on the management of drug resistance for regimen selection and switching
Reduced incidence of acquired HIV Drug Resistance
Reduced HIV-related morbidity and mortality
Conduct open case conferences with NGOs at the National Care and Treatment Center (NCTC)
Reduced loss to care
Increased rate of patient re-engagement after loss to care
Increased proportion of patients retained in care
Improved quality of HIV care
Reduced HIV-related morbidity and mortality
Conduct routine adherence assessments and transmission risk reassessment among retained care clients
Improved detection of adherence challenges
Reduced incidence of treatment failure
Reduced incidence of acquired drug resistance
Improved quality of HIV clinical care
Reduced viral load
Reduced incidence of opportunistic infections
Develop and pilot an HIV/AIDS-specific quality improvement strategy and assessment tool for laboratory services
Increased availability of strategic information around laboratory performance
Reduced turnaround time for HIV confirmatory test results
Increased quality checks for rapid testing using gold standards (ELISA and Western Blot)
Improved quality of laboratory service delivery
Maintenance of a safe blood supply
Conduct an HIV drug resistance capacity assessment at national public health reference laboratory (NPHRL)
Increased availability of strategic information around HIVDR testing at NPHRL
Increased data for decision making ability around initiating HIVDR testing locally and the required inputs
Monitor current infection control practices at HIV and TB care sites
Decreased risk of TB/HIV nosocomial infections
Decreased incidence of TB among HIV-infected patients in care
Reduced TB/HIV-related morbidity and mortality for the coinfected
Develop a clinical cascade at the national level for ongoing program monitoring and evaluation (M&E)
Improved program management by highlighting areas of need across the continuum of care
Improved program quality
Reduced HIV-related morbidity and mortality
Establish and build capacity for Caribbean regional support, including analysis
Increased collaboration with peers and technical support resources within the Caribbean region
Increased availability of sustainable HIV technical assistance outside of USG or international multilaterals
Federal Grant Title: | Building Capacity for a Sustainable, Country-led Response to the HIV/AIDS Epidemic in Guyana: A Technical Assistance Support Model to the Guyana Ministry of Health (MOH) under the President's Emergency Plan for AIDS |
Federal Agency Name: | Centers for Disease Control and Prevention |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | CDC-RFA-GH15-1525 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.067 |
CFDA Descriptions: | Global AIDS |
Current Application Deadline: | Jan 23, 2015 Electronically submitted application |
Original Application Deadline: | Jan 23, 2015 Electronically submitted application |
Posted Date: | December 1st, 2014 |
Creation Date: | Dec 1, 2014 |
Archive Date: | Feb 22, 2015 |
Total Program Funding: | $690,000 |
Maximum Federal Grant Award: | $3,450,000 |
Minimum Federal Grant Award: | $0 |
Expected Number of Awards: | 1 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Ministry of Health, Guyana
- Link to Full Grant Announcement
- Grant Announcement Contact
- Yoran Grant-Greene, Project Officer
[email protected]
Grants Policy
Centers for Disease Control and Prevention 770-488-2756 - Similar Government Grants
- • Technical Assistance to Deliver Comprehensive HIV/AIDS Prevention, Care and Treatment Acti...
- • Building an Effective, Robust and Sustainable Integrated Sample Transportation System in C...
- • Strengthening Mozambique's Capacity to Integrate and Sustain High-Quality Laboratory Servi...
- • Enhancing HIV Prevention, Care and Treatment Services through Patient Empowerment, Communi...
- • Implementing Evidence-Based Prevention Interventions for Key and Priority Populations in t...
- • Expansion and Support of HIV/AIDS/STI/TB Information, Education, and Communication and Beh...
- • Increasing Access to HIV Counseling and Testing (VCT) and Enhancing HIV/AIDS Communication...
- • Cooperative Agreement for Global Capacity through Internation NGO Partnership
- More Grants from the Centers for Disease Control and Prevention
- • Advancing Diagnostic Network Optimization, Stepwise Laboratory Accreditation, and Integrat...
- • Strengthening Public Health Systems and Services through National Partnerships to Improve ...
- • 93.067
- • Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...
- • Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...